Subcellular distribution of protein phosphatases and abnormally phosphorylated τ in the temporal cortex from Alzheimer's disease and control brains

被引:0
|
作者
J.-J. Pei
C.-X. Gong
K. Iqbal
I. Grundke-Iqbal
Q. L. Wu
B. Winblad
R. F. Cowburn
机构
[1] Karolinska Institute,
[2] Department of Clinical Neuroscience and Family Medicine,undefined
[3] Section for Geriatric Medicine,undefined
[4] Novum,undefined
[5] KFC,undefined
[6] Huddinge,undefined
[7] Sweden,undefined
[8] NYS Institute for Basic Research in Developmental Disabilities,undefined
[9] Staten Island,undefined
[10] NY,undefined
[11] U.S.A.,undefined
来源
关键词
Keywords: Protein phosphatases; AD P-tau; subcellular fractions; indirect enzyme-linked immunosorbent assay (ELISA); Alzheimer's disease.;
D O I
暂无
中图分类号
学科分类号
摘要
Microtubule-associated protein tau is abnormally hyperphosphorylated in the brain of patients with Alzheimer's disease (AD). In vitro studies have shown that protein phosphatases PP-2A and PP-2B can convert Alzheimer like tau to its normal state and that the activities of PP-1, PP-2A, and phosphotyrosyl-protein phosphatase (PTP) are reduced in AD brain. However, to have a direct effect on the regulation of phosphorylation on tau, these enzymes have to exist in neurons. Using specific polyclonal antibodies the levels of protein phosphatases PP-1, PP-2A, and PP-2B were determined by indirect ELISA in superior temporal cortical gray matter of AD and control brains. The protein levels of PP-2A and PP-2B were significantly increased in postsynaptosomal supernatant 2 (S2) of the AD group, and this alteration showed a significant linear correlation with levels of hyperphosphorylated tau. PP-1 and PTP-1B levels were not significantly changed in any of the AD fractions. Because of the large variation from case to case, the activity levels of none of the phosphatases investigated were significantly different between the AD and control groups. However, the PP-2B specific activity (activity/protein) showed a significant linear inverse correlation with hyperphosphorylated tau. These studies suggest that any attempt by the AD brain to compensate for the decreased tau phosphatase activity remains unsuccessful and that the decrease in phosphatase activity might contribute to increased levels of abnormally phosphorylated tau.
引用
收藏
页码:69 / 84
页数:15
相关论文
共 50 条
  • [41] Protein synthesis in the posterior cingulate cortex in Alzheimer's disease
    Yoshida, Tetsuhiko
    Kazui, Hiroaki
    Tokunaga, Hiromasa
    Kito, Yumiko
    Kubo, Yoshihiko
    Kimura, Nobuyo
    Morihara, Takashi
    Shimosegawa, Eku
    Hatazawa, Jun
    Takeda, Masatoshi
    PSYCHOGERIATRICS, 2011, 11 (01) : 40 - 45
  • [42] G-protein α-subunit levels in hippocampus and entorhinal cortex of brains staged for Alzheimer's disease neurofibrillary and amyloid pathologies
    García-Jiménez, A
    Fastbom, J
    Ohm, TG
    Cowburn, RF
    NEUROREPORT, 2003, 14 (11) : 1523 - 1527
  • [43] Cerebrospinal fluid tau, Aβ, and phosphorylated tau protein for the diagnosis of Alzheimer's disease
    Formichi, Patrizia
    Battisti, Carla
    Radi, Elena
    Federico, Antonio
    JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 208 (01) : 39 - 46
  • [44] ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain
    Herrmann, M
    Golombowski, S
    Kräuchi, K
    Frey, P
    Mourton-Gilles, C
    Hulette, C
    Rosenberg, C
    Müller-Spahn, F
    Hock, C
    EUROPEAN NEUROLOGY, 1999, 42 (04) : 205 - 210
  • [45] SUBCELLULAR-DISTRIBUTION IN CEREBRAL-CORTEX OF 2 PROTEINS PHOSPHORYLATED BY A CAMP-DEPENDENT PROTEIN-KINASE
    UEDA, T
    GREENGARD, P
    BERZINS, K
    COHEN, RS
    BLOMBERG, F
    GRAB, DJ
    SIEKEVITZ, P
    JOURNAL OF CELL BIOLOGY, 1979, 83 (02): : 308 - 319
  • [47] Phosphorylated Ribosomal Protein S6 is Greatly Increased in Alzheimer Disease
    Smith, Mark
    Gupta, Yashi
    Siedlak, Sandra
    Harris, Peggy
    Coller, Jeffrey
    Perry, George
    Zhu, Xiongwei
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (05): : 523 - 523
  • [48] Assessment of protein kinase C mRNA levels in Alzheimer's disease brains
    Chachin, M
    Shimohama, S
    Kunugi, YU
    Taniguchi, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 1996, 71 (02): : 175 - 177
  • [49] Localization of Thioredoxin-Interacting Protein in Aging and Alzheimer's Disease Brains
    Tsubaki, Haruka
    Mendsaikhan, Anarmaa
    Buyandelger, Undral
    Tooyama, Ikuo
    Walker, Douglas G.
    NEUROSCI, 2022, 3 (02): : 166 - 185
  • [50] Immunohistochemical characterization of γ-secretase activating protein expression in Alzheimer's disease brains
    Satoh, J.
    Tabunoki, H.
    Ishida, T.
    Saito, Y.
    Arima, K.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2012, 38 (02) : 132 - 141